OHI · NYSE
Omega Healthcare Investors (OHI) Stock Price & Fundamentals
Omega Healthcare Investors (OHI) closed at $745.18 on Oct 9, 2026, up 0.42% from the previous close of $742.07.
Share price, past year
1Y +8.01%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $745.18 |
| Sep 30, 2026 | $747.14 |
| Aug 31, 2026 | $732.58 |
| Jul 31, 2026 | $756.11 |
| Jun 30, 2026 | $760.49 |
| May 29, 2026 | $805.25 |
| Apr 30, 2026 | $750.64 |
| Mar 31, 2026 | $814.39 |
| Feb 27, 2026 | $779.10 |
| Jan 30, 2026 | $740.09 |
| Dec 31, 2025 | $740.59 |
| Nov 28, 2025 | $688.51 |
| Oct 31, 2025 | $705.68 |
Key statistics
- Market cap
- $222.89B
- P/E (TTM)
- 265.2
- EPS (TTM)
- $2.81
- Revenue (TTM)
- $1.28B
- Net income (TTM)
- $858.43M
- Shares outstanding
- 299.1M
- Dividend yield
- 0.36%
- 52-week range
- $680.84 – $814.39
Omega Healthcare Investors's market cap is $222.89B, based on a share price of $745.18 and 299.1M shares outstanding as of Jun 30, 2026.
Financials
Omega Healthcare Investors reported revenue of $1.19B for fiscal 2025, up 13.19% from fiscal 2024.
Omega Healthcare Investors earned net income of $590.19M in fiscal 2025, a net margin of 49.6%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.19B | +13.2% | $590.19M | 49.6% | $1.94 | — |
| FY2024ended Dec 31, 2024 | $1.05B | +10.7% | $406.33M | 38.7% | $1.55 | — |
| FY2023ended Dec 31, 2023 | $949.74M | +8.1% | $242.18M | 25.5% | $1.00 | — |
| FY2022ended Dec 31, 2022 | $878.24M | −17.4% | — | — | $1.80 | — |
| FY2021ended Dec 31, 2021 | $1.06B | +19.1% | — | — | $1.75 | — |
| FY2020ended Dec 31, 2020 | $892.38M | −3.9% | — | — | $0.70 | — |
| FY2019ended Dec 31, 2019 | $928.83M | +5.4% | — | — | $1.58 | — |
| FY2018ended Dec 31, 2018 | $881.68M | −2.9% | — | — | $1.40 | — |
| FY2017ended Dec 31, 2017 | $908.39M | +0.8% | — | — | $0.51 | — |
| FY2016ended Dec 31, 2016 | $900.83M | — | — | — | $1.90 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $328.25M | $362.82M | $1.19 |
| Q1 FY2026ended Mar 31, 2026 | $322.96M | $151.05M | $0.47 |
| Q4 FY2025ended Dec 31, 2025 | $319.22M | $164.84M | $0.56 |
| Q3 FY2025ended Sep 30, 2025 | $311.59M | $179.72M | $0.59 |
| Q2 FY2025ended Jun 30, 2025 | $282.51M | $136.60M | $0.46 |
| Q1 FY2025ended Mar 31, 2025 | $276.79M | $109.03M | $0.33 |
| Q4 FY2024ended Dec 31, 2024 | $279.32M | $113.34M | $0.41 |
| Q3 FY2024ended Sep 30, 2024 | $276.03M | $111.76M | $0.42 |
Company profile
- Name
- Omega Healthcare Investors, Inc.
- Ticker
- OHI
- Exchange
- NYSE
- Industry (SEC SIC)
- Real Estate Investment Trusts
- Headquarters
- 303 International Circle,, Suite 200, Hunt Valley, MD 21030
- Incorporated in
- MD
- Fiscal year ends
- December
- SEC CIK
- 0000888491
Recent SEC filings
- Oct 5, 2026
- Oct 1, 2026
- Jul 30, 2026
- Jul 29, 2026
- Jun 5, 2026
- May 21, 2026
- Apr 29, 2026
- Apr 28, 2026
Frequently asked questions
What is Omega Healthcare Investors's stock price?
Omega Healthcare Investors (OHI) closed at $745.18 on Oct 9, 2026, up 0.42% from the previous close of $742.07.
What is Omega Healthcare Investors's market cap?
Omega Healthcare Investors's market cap is $222.89B, based on a share price of $745.18 and 299.1M shares outstanding as of Jun 30, 2026.
How much revenue does Omega Healthcare Investors make?
Omega Healthcare Investors reported revenue of $1.19B for fiscal 2025, up 13.19% from fiscal 2024.
What is OHI's P/E ratio?
Omega Healthcare Investors's price-to-earnings ratio is 265.2, based on trailing twelve-month diluted EPS of $2.81.
Does Omega Healthcare Investors pay a dividend?
Yes. Omega Healthcare Investors declared $2.68 per share in dividends over the last four quarters, a yield of 0.36%.
Sources and methodology
Fundamentals come from Omega Healthcare Investors, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures